Potassium Chloride 0.15% w/v & Glucose 5% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

potassium chloride 0.15% w/v & glucose 5% w/v solution for infusion

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.15 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes

Potassium Chloride 0.3% w/v & Glucose 5% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

potassium chloride 0.3% w/v & glucose 5% w/v solution for infusion

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.3 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes.

Neoparen No.2 Injection Suspension Philippines - English - FDA (Food And Drug Administration)

neoparen no.2 injection suspension

otsuka phils inc - carbohydrate, electrolyte, amino acid and multivitamin - suspension

Neoparen No.1 Injections Solution for IV injection Philippines - English - FDA (Food And Drug Administration)

neoparen no.1 injections solution for iv injection

otsuka phils pharma'l inc - carbohydrate, electrolytes, amino acids and multivitamins - solution for iv injection

AMINOPLASMAL 10% E WITHOUT CARBOHYDRATES SOLUTION Ireland - English - HPRA (Health Products Regulatory Authority)

aminoplasmal 10% e without carbohydrates solution

b. braun medical limited - leucine isoleucine lysine hydrochloride dl-methionine phenylalanine threonine tryptophan, l- valine arginine histidine aminoacetic acid alanine proline aspartic acid aspargine monohydrate acetylcysteine glutamic acid ornithine hydrochloride serine tyrosine sodium acetate trihydrate potassium acetate magnesium acetate tetrahydrate sodium phosphate monobasic malic acid n-acetyltyrosine ph. eur. - solution for infusion - 10 %w/v

AMINOPLASMAL 5% E WITHOUT CARBOHYDRATES SOLUTION F Ireland - English - HPRA (Health Products Regulatory Authority)

aminoplasmal 5% e without carbohydrates solution f

b. braun medical limited - isoleucine leucine lysine hydrochloride dl-methionine phenylalanine threonine tryptophan, l- valine arginine histidine aminoacetic acid alanine proline aspartic acid aspargine monohydrate acetylcysteine glutamic acid ornithine hydrochloride serine tyrosine sodium acetate trihydrate potassium acetate magnesium acetate tetrahydrate sodium dihydrogen phosphate dihydrate malic acid n-acetyltyrosine ph. eur. - solution for infusion - 5 %w/v

AMINOPLASMAL 10% E WITHOUT CARBOHYDRATES SOLUTION 10 %w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

aminoplasmal 10% e without carbohydrates solution 10 %w/v solution for infusion

b. braun medical limited - leucine isoleucine lysine hydrochloride dl-methionine phenylalanine threonine tryptophan, l- valine arginine histidine aminoacetic acid alanine proline aspartic acid aspargine monohydrate acetylcysteine glutamic acid ornithine hydrochloride serine tyrosine sodium acetate trihydrate potassium acetate magnesium acetate tetrahydrate sodium phosphate monobasic malic acid n-acetyltyrosine ph. eur. - solution for infusion - 10 %w/v

AMINOPLASMAL 5% E WITHOUT CARBOHYDRATES SOLUTION F 5 %w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

aminoplasmal 5% e without carbohydrates solution f 5 %w/v solution for infusion

b. braun medical limited - isoleucine leucine lysine hydrochloride dl-methionine phenylalanine threonine tryptophan, l- valine arginine histidine aminoacetic acid alanine proline aspartic acid aspargine monohydrate acetylcysteine glutamic acid ornithine hydrochloride serine tyrosine sodium acetate trihydrate potassium acetate magnesium acetate tetrahydrate sodium dihydrogen phosphate dihydrate malic acid n-acetyltyrosine ph. eur. - solution for infusion - 5 %w/v

GLUCAGEN HYPOKIT 1mg powder for injection vial with diluent syringe Australia - English - Department of Health (Therapeutic Goods Administration)

glucagen hypokit 1mg powder for injection vial with diluent syringe

novo nordisk pharmaceuticals pty ltd - glucagon, quantity: 1 mg (equivalent: glucagon, qty 1 iu) - diluent, not applicable - excipient ingredients: water for injections - therapeutic: treatment of severe hypoglycaemic reactions which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents. to prevent the occurrence of secondary hypoglycaemia, oral carbohydrate should be given to restore the hepatic glycogen when the patient has responded to the treatment. the mechanism and hence treatment of sulfonylurea-induced hypoglycaemia differs from that of severe insulin-induced hypoglycaemia in some important ways. consciousness should preferably be restored by the administration of intravenous glucose. if glucagon is used due to the unavailability of intravenous glucose (e.g. before reaching a hospital) care should be taken to protect against secondary hypoglycaemia with constant monitoring of the patient's blood sugar level by medical personnel. subsequent administration of intravenous glucose may be required.,diagnostic: motility inhibitor in examinations of the gastrointestinal tract in adults, e.g. double contrast radiography and endoscop